Global public-private partnerships: Part II - What are the health issues for global governance?

Bulletin of the World Health Organization

Volumn 78, Issue 5, 2000, Pages 699-709

  Buse, K ^a   Walt, G ^b  

^a YALE UNIVERSITY   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Developing countries; Intersectoral cooperation, history; Private sector; Public sector; United Nations; World health, trends

Indexed keywords

HEALTH CARE; HEALTH SERVICES; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP;

COMPETENCE; DEVELOPING COUNTRY; DRUG INDUSTRY; GOVERNMENT; HEALTH PROGRAM; INTERNATIONAL COOPERATION; MOTIVATION; ORGANIZATION AND MANAGEMENT; REVIEW; UNITED NATIONS;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; PRIVATE SECTOR; PUBLIC SECTOR; SOCIAL JUSTICE; WORLD HEALTH;

EID: 0034046491     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Mitchell-Weaver C, Manning B. Public-private partnerships in Third World development. The 20th Norma Wilkinson Memorial Lecture. Geographical Paper. Reading, Reading University, 1990.
2. Leading companies to mobilize against global A IDS epidemic. Press Release. Geneva, UNAIDS, 23 October 1997.
3. Chernesky MA. How can industry, academia, public health authorities and the Sexually Transmitted Diseases Diagnostics Initiative work together to help control sexually transmitted diseases in developing countries? Sexually Transmitted Diseases, 1997, 24 (2): 61-63.
4. Ridley R, Gutteridge WE, Currat LJ. New Medicines for Malaria Venture: a case study of the establishment of a public sector - private sector partnership. Paper presented at the Third Global Forum for Health Research, 8-11 June 1999, Geneva.
5. Berkley S, Lenton C. The International AIDS Vaccine Initiative. Paper presented at the Third Global Forum for Health Research, 8-11 June 1999, Geneva.
6. Kickbusch I, Quick J. Partnerships for health in the 21st century. World Health Statistics Quarterly, 1998, 51: 69.
7. WHO European partnership project on tobacco dependence. Draft document. Geneva, World Health Organization, 22 December 1998.
8. Public-Private Partnership Programme of UNDP. Internet communication on November 12 1999 at http:/www.undp.org/ info21/business/annex3.html
9. Letter from SG Cowal, Director of External Relations, UNAIDS, to undisclosed recipient dated 19 January 1999. Geneva, UNAIDS, 1999.
10. UNAIDS launches initiative to help bridge gap in access to HIV/ AIDS-related drugs in developing world. Press Release. Geneva, UNAIDS, 5 November 1997.
11. Guidelines for drug donations. Geneva, World Health Organization, May 1996.
12. Godal T. Fighting parasites of poverty: public research, private industry and tropical disease. Science, 1994, 264: 1864-1866.
13. Finance report of the International AIDS Vaccine Initiative: accelerating the development of preventive HIV vaccines for the world. New York, International AIDS Vaccine Initiative, 1995.
14. Malaria Vaccine Initiative: statement of purpose. Seattle, WA, Program for Appropriate Technology in Health, 1999.
15. Bristol-Myers Squibb commits $ 100 million for HIV/AIDS research and community outreach in five African countries. Press release, Washington, DC, 6 May 1999.
16. Innovative private sector venture under way. TDK News, 1999, 58:3.
17. Roll Back Malaria: report by the Director-General to the Fifty Second World Health Assembly. Provisional agenda item, 13 May 1999. Geneva, World Health Organization.
18. Nunn P. Personal communication with Head, Stop TB Initiative. London, 18 June 1999.
19. Annan K. Address to the US Chambers of Commerce, 8 June 1999, Washington, DC.
20. Walt G. International organisations in health: the problem of leadership. In: Pocantico Retreat: Enhancing the performance of international health institutions. Rockefeller Foundation, Social Science Research Council, Harvard School of Health, 1999.
21. Hancock T. Caveat partner: reflections on partnership with the private sector. Health Promotion International, 1998, 13 (3): 193.
22. Lenton C. Remarks made at parallel session number 7.1 at the Global Forum for Health Research, 8 June 1999, Geneva.
23. Frost L, Reich M. Mectizan® Donation Program: origins, experiences, and relationships with co-ordinating bodies for onchocerciasis control. Department of Population and International Health. Boston, Harvard School of Public Health, 1998.
24. Widdus R, Evans P. Lessons learned from the Children's Vaccine Initiative 1990-1999. Paper presented at the Third Global Forum for Health Research, Geneva, 9 June 1999.
25. Bellamy C. Public, private and civil society. Statement of UNICEF Executive Director to Harvard International Development Conference on 'Sharing responsibilities: public, private and civil society.' Cambridge, MA, 16 April 1999.
26. Dukes G. The contribution of the private sector: an introduction. Australian Prescriber, 1997, 20 (Suppl 1): 74-75.
27. Klein N. UN pact with business masks real dangers. Toronto Star, 19 March 1999.
28. WHO guidelines on collaboration and partnerships with commercial enterprises. Draft discussion document dated 24 July 1999. Geneva, World Health Organization, 1999.
29. Deen T. UN calls for new partnership with arms industry. InterPress Service Daily Journal, 7 (129), 7 July 1999. Internet communication at http:/www.globalpolicy.org/reform/ armsindy.htm
30. Rosenau JN. Governance in the twenty-first century. Global Governance, 1995, 1 (1): 13-43.
31. World Bank. Governance: the World Bank's experience. Washington, DC, World Bank, 1994.
32. Mabey D. Personal communication, Member of Technical Expert Committee, International Trachoma Initiative, London, 28 June 1999.
33. Haas PM. Do regimes matter? Epistemic communities and Mediterranean pollution control. International Organisation, 1989, 43 (3).
34. Bain K. Building or burning bridges? The accountability of transnational NGO networks in policy alliances with the World Bank. Paper prepared for the Conference on NGOs in a Global Future, Birmingham 1999.
35. Bill and Melinda Gates Children 's Vaccine Program: Outline tor Action Seattle, WA, Program for Appropriate Technology in Health, 1998.
36. Cook J. Personal correspondence with J Cook, Executive Director, International Trachoma Initiative, 20 May 1999.
37. Muraskiri W. The war against hepatitis B: A history of the International Task Force on Hepatitis B Immunization. Philadelphia, Pennsylvania University Press, 1995.
38. International guidelines for ethical review of epidemiological studies. Geneva, Council for International Organizations of Medica Sciences, 1991.
39. Khan P. UNAIDS to publish guidelines on ethics of vaccine trials. International AIDS Vaccine Initiative Report, Spring 1999. New York IAVI, 1999.
40. Proposed programme budget for the financial period 1998-1999. Geneva, World Health Organization, 1996.
41. Eckholm E. River blindness - Conquering an ancient scourge. The New York Times Magazine, 8 January 1989.
42. Bristol-Myers Squibb 'Secure the future' announcement and media reaction. Internet posting from the Treatment Access Forum. Internet communication, 11 May 1999 at http://www.hivnet.ch: 8000/treatment-access/tdm
43. Chetley A. A healthy business? World health and the pharmaceutical industry. London, Zed Books, 1990.
44. Lucas A. Personal communication, 13 July 1999.
45. Kale OO. Review of disease-specific corporate drug donation programmes for the control of communicable diseases. Paper presented at the Symposium: Drugs for Communicable Diseases -Stimulating development and availability, Paris, 15 October 1999.
46. Drager N et al. What determines aid for health: an empirical analysis o bilateral aid flows. International Conference on Macro-Economics and Health in Countries in Greatest Need. Geneva, World Health Organization, 1992.
47. Weber J, Barrett A. Volatile combos: pharmaceutical alliances can boost both players' health - or drag them down. Business Week, 25 October 1999.
48. Korten D. The United Nations and the corporate agenda Text circulated on the internet, July 1997. Internet communication at http://www.igc.org/globalpolicy/reform/korten.htm
49. Foege WH. Ten years of Mectizan. Annals of Tropical Medicine and Parasitology, 1998, 92 (1): 7-10.
50. Towards the creation of strategic partnerships: improving access to drugs tor HIV/AIDS: report of a consultative meeting, 30 June-2 July 1997, World Health Organization, Geneva. Geneva, LiNAIDS, 1997.